Gordon Byrnes, MD
Retina Specialist · Alexandria, VANPI 1295709699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Apellis Pharmaceuticals, Inc. at 25.8% of the total. 2025 is the largest year on record at $931, 4.0 times the $231 reported in 2019.
Across 93 payments — averaging $30.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$725
- Regeneron Healthcare Solutions, Inc.$690
- AbbVie$324
- Genentech USA, Inc.$322
- Astellas Pharma US Inc$223
- Bausch & Lomb Americas Inc.$174
- plus $352 from 8 others
What the payments were for
- Food & beverage$2,811100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 15 | $725 |
| Regeneron Healthcare Solutions, Inc. | 20 | $690 |
| AbbVie(2 entities) | 14 | $324 |
| Genentech USA, Inc. | 14 | $322 |
| Astellas Pharma US Inc | 8 | $223 |
| Bausch & Lomb Americas Inc. | 8 | $174 |
| Novartis | 4 | $82 |
| Harrow Eye, LLC | 3 | $69 |
| Vertos Medical, Inc. | 1 | $52 |
| Amgen | 2 | $47 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| Alimera Sciences, Inc. | 1 | $28 |
| Coherus Oncology, Inc. | 1 | $26 |
| Shire North American Group Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Syfovre$241
How this compares
$2,811 in reported general payments places this provider in the 60th percentile of 41 retina specialist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 95 | $3,290 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 16 | $1,251 |
| Difluprednate | 13 | $1,097 |
| Timolol Maleate | 68 | $900 |
| Ofloxacin | 60 | $737 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 15 | $667 |
| Brimonidine Tartrate | 41 | $583 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 21 | $490 |
| Latanoprost | 42 | $412 |
| ErythromycinErythromycin Base | 11 | $113 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Alexandria
- Sundeep KasiAlexandria$4K
- Reshma KatiraAlexandria$2K
- Jordana FeinManassas$412K
- Joaquin TosiVirginia Beach$48K
- Mohit NandaCharlottesville$31K
- Muge KesenMc Lean$30K
- Anna MackinRoanoke$26K
- Jon AdlebergChesapeake$21K
- Dal ChunVienna$12K
- Kori ElkinsPortsmouth$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.